Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹56.70Admitted-Finance | ₹56.70 | L1 | Admitted-Finance |
| 2 | L2₹136.50Admitted-Finance | ₹136.50 | L2 | Admitted-Finance |
| 3 | L3₹199.50Admitted-Finance | ₹199.50 | L3 | Admitted-Finance |
| 4 | L4₹848.40Admitted-Finance | ₹848.40 | L4 | Admitted-Finance |
| 5 | L5₹49,473.69Admitted-Finance 501 ARENA SPACE BEHIND MAJAS BUS DEPOT OFF J V LINK ROAD JOGESHWARI EAST MUMBAI MAHARASHTRA 400060 | MUMBAI SUBURBAN | MAHARASHTRA | 400060 | ₹49,473.69 | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Novo Nordisk India Private Limited L6 | Johnson and Johnson Pvt. Ltd. L5 | Venus Remedies Ltd. L4 | INNOVA CAPTAB LTD. L1 | MALIK LIFESCIENCES PVT LTD L3 | AstraZeneca Pharma India Limited L7 | ALKEM LABORATORIES LIMITED L2 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | Silver Sulphadiazine cream IP 1% [224] | 18,66,542.7 | 50 gm Tube (Rate should be quoted Single Unit) | - | - | - | - | - | - | - |
| 2.00 | Ceftriaxone 1000mg and Salbactum 500mg and Disodium Edetate 37mg Inj [NRD-185] | 4,18,389.4 | vial / Amp (Rate should be quoted Single Unit) | - | - | 808 ₹848.4 | 54 ₹56.7 Lowest | 190 ₹199.5 | - | 130 ₹136.5 |
| 3.00 | Daratumumab400 mg Inj. [NRD-203] | 2,729.1 | vial / Amp (Rate Should be quoted for single unit) | - | 49,473.69 ₹49,473.69 Lowest | - | - | - | - | - |
| 4.00 | Durvalumab 500mg Inj. [NRD-223] | 700.7 | vial / Amp (Rate Should be quoted for Single vial / Amp ) | - | - | - | - | - | 1,11,605.52 ₹1,17,185.8 Lowest | - |
| 5.00 | Nimotuzumab 50 mg Inj. [NRD-312] | 7,794 | vial / Amp (Rate should be quoted Single Unit) | - | - | - | - | - | - | - |
| 6.00 | Glycopegylated Extended Half Life Nonacog Beta pegol F IX 500 IU [NRD-889] | 1,515.8 | Vial (Rate should be quoted Single Unit) | - | - | - | - | - | - | - |
| 7.00 | Glycopegylated Extended Half Life Nonacog Beta pegol F IX 1000 IU [NRD-890] | 1,479.5 | Vial (Rate should be quoted Single Unit) | 85,400 ₹89,670 Lowest | - | - | - | - | - | - |
Tender Value
₹86.2 Cr
EMD Value
₹1.7 Cr
Closing Date
20 Jul 2026, 6:00 pmClosed
MD RMSCL
Rajasthan Medical Services Corporation Limited, Gandhi Block, Swasthya Bhawan, Tilak Marg, CScheme, Jaipur-302005 (Raj.)
NOTICE INVITING E-Bids Short Term e- Bids are invited by RMSCL, Jaipur from bonafide MANUFACTURERS / LOAN LICENSEE / IMPORTERS / CO-MARKETERS
2026_RMSCL_570736_1
RMSC/PRO/DRUG/NIB-03/2026/4494 Dt.24.06.2026
Open Tender
Supply of Materials/Hiring of Goods
Item Rate
75 days
All Rajasthan
As Per Bid Document
4 documents required · 4 mandatory
₹2,360
Yes
MD RMSCL
₹1.7 Cr
Yes
RMSCL (BOARD ROOM)
3 Aug 2026
24 Jun 2026
21 Jul 2026
24 Jun 2026
20 Jul 2026
5 Jul 2026
3 Jul 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | Silver Sulphadiazine cream IP 1% [224] | 18,66,542.7 | 50 gm Tube (Rate should be quoted Single Unit) | - | - |
| 2 | Ceftriaxone 1000mg and Salbactum 500mg and Disodium Edetate 37mg Inj [NRD-185] | 4,18,389.4 | vial / Amp (Rate should be quoted Single Unit) | - | - |
| 3 | Daratumumab400 mg Inj. [NRD-203] | 2,729.1 | vial / Amp (Rate Should be quoted for single unit) | - | - |
| 4 | Durvalumab 500mg Inj. [NRD-223] | 700.7 | vial / Amp (Rate Should be quoted for Single vial / Amp ) | - | - |
| 5 | Nimotuzumab 50 mg Inj. [NRD-312] | 7,794 | vial / Amp (Rate should be quoted Single Unit) | - | - |
| 6 | Glycopegylated Extended Half Life Nonacog Beta pegol F IX 500 IU [NRD-889] | 1,515.8 | Vial (Rate should be quoted Single Unit) | - | - |
| 7 | Glycopegylated Extended Half Life Nonacog Beta pegol F IX 1000 IU [NRD-890] | 1,479.5 | Vial (Rate should be quoted Single Unit) | - | - |
stage.html
html • 0.04 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.04 MB
Tendernotice_1.pdf
PDF • 0.25 MB
NIB03.pdf
Tender Documents • 24.05 MB
BOQ_1015517.xls
BOQ • 0.24 MB
4627CorrigendumIII.pdf
PDF • 0.03 MB
4603Dis.pdf
PDF • 0.25 MB
4533.pdf
PDF • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].